Praxis Precision Medicines, Inc. (PRAX)
PRAX price $256.10 -8.39 -3.17%
- Ticker
- PRAX
- Price
- $256.10
- Change
- -8.39 -3.17%
- Market cap
- $7.15B
- P/E
- -20.42
- Forward P/E
- 47.70
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which…